What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?

被引：6
|
作者：
Vanoli, Fiammetta [1 ,2 ]
Mantegazza, Renato [1 ]
机构：
[1] Fdn IRCCS Ist Neurol Carlo Besta, Neuroimmunol & Neuromuscular Dis Dept, Milan, Italy
[2] Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2022年 / 23卷 / 13期
关键词：
Myasthenia gravis; monoclonal antibodies; immunosuppression; biological drugs; C5; FcRn; RITUXIMAB;
D O I：
10.1080/14656566.2022.2122710
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1471 / 1474
页数：4
相关论文
共 50 条
  • [1] Current pharmacotherapeutic options for myasthenia gravis
    Barnett, Carolina
    Tabasinejad, Raha
    Bril, Vera
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (18) : 2295 - 2303
  • [2] PHARMACOLOGICAL CONSIDERATIONS IN THE TREATMENT OF MYASTHENIA GRAVIS
    GLASER, GH
    ADVANCES IN PHARMACOLOGY, 1963, 2 : 113 - 160
  • [3] Treatment considerations in myasthenia gravis for the pregnant patient
    Gilhus, Nils Erik
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (02) : 169 - 177
  • [4] What Is Myasthenia Gravis?
    Marcus, Revital
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (05): : 452 - 452
  • [5] The treatment of myasthenia gravis patients undergoing thymectomy - Anesthesiologic considerations
    MajericKogler, V
    Sostarko, M
    Slobodnjak, Z
    Hodoba, N
    Karadza, J
    Vladovic, T
    NEUROLOGIA CROATICA, 1996, 45 (2-3): : 77 - 86
  • [6] Perianesthetic Implications and Considerations for Myasthenia Gravis
    Muckler, Virginia C.
    O'Brien, Jennifer M.
    Matson, Stephen E.
    Rice, Andi N.
    JOURNAL OF PERIANESTHESIA NURSING, 2019, 34 (01) : 4 - 15
  • [7] Anaesthetic Considerations in Paediatric Myasthenia Gravis
    Masters, Oliver William
    Bagshaw, Oliver N.
    AUTOIMMUNE DISEASES, 2011, 2011
  • [8] Treatment of myasthenia gravis
    Viets, HR
    LANCET, 1944, 1 : 33 - 34
  • [9] Treatment of Myasthenia Gravis
    Kumar, Vikas
    Kaminski, Henry J.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (01) : 89 - 96
  • [10] Treatment of myasthenia gravis
    Foster, Jean
    AUSTRALIAN PRESCRIBER, 2008, 31 (03) : 60 - 60
12345